Pharmaceutical company 4D Pharma reported on Wednesday that its lead oncology candidate has demonstrated immune-stimulatory characteristics in pre-clinical models. The MRx0518 is a strain of live b...
Original Article: 4D Pharma cancer treatment shown to stimulate immune system response
NEXT ARTICLE